Bergaptol

Overview

Bergaptol is an inhibitor of debenzylation of the CYP3A4 enzyme with an IC 50 of 24.92 μM. Recent studies have shown that it has anti-proliferative and anti-cancer properties.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Free Radical Scavengers | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-76316
• CAS No.: 486-60-2
• Molecular Formula: C11H6O4
• Molecular Weight: 202.16
• Purity: 99.30%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.5 mg/mL (12.37 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source